8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Jul 15, 2020 · 6y ago · Accession 0001193125-20-193348
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Cue Biopharma, Inc.
- Ticker
- CUE
- CIK
- 1645460
- Form type
- 8-K
- Filing date
- Jul 15, 2020
- Report date
- Jul 9, 2020
- Document
- d73475d8k.htm
- Size
- 33 KB